definiens: means ( a ) each antibody that has the same sequence of any antibody generated from use of the Adimab Platform Technology and delivered by Adimab to Tusk and/or Blac k Belt under the CD38 Research Program or * * * ( including Bispecifics ) and ( b ) each antibody that has the same sequence of any antibody generated from use of the Adimab Platform Technology and delivered by Adimab to Black Belt under a Research Program ( incl uding Bispecifics ) . It is understood and agreed that ( i ) it is the intention of the Parties that Adimab will send samples as well as sequence information with respect to each Program Antibody as agreed upon by the Parties ; and ( ii ) even if Adimab sends onl y nucleic acid sequences to Black Belt ( or has sent such nucleic acid sequences to Tusk under the Original Tusk Agreement ), antibodies encoded by such nucleic acid sequences are Program Antibodies in addition to antibodies samples of which are physically d elivered to Black Belt under this Agreement ( or to Tusk under the Original Tusk Agreement ) so long as : ( a ) Adimab first coordinates with Black Belt prior to sending such sequences to confirm that Black Belt wishes to receive such sequences ; and ( b ) if Blac k Belt identifies any sequences with respect to which Adimab did not deliver protein, then Adimab delivers to Black Belt the protein samples of such antibodies within thirty ( 30 ) days after Black Belt ’s identification